Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

Fung S., Kwan P., Fabri M., Horban A., Pelemis M., Hann H., ...Daha Fazla

GASTROENTEROLOGY, cilt.146, sa.4, ss.980-989, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 146 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1053/j.gastro.2013.12.028
  • Dergi Adı: GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.980-989
  • Anahtar Kelimeler: HBV DNA, Hepatitis B e Antigen, Renal Function, Viral Suppression, BONE-MINERAL DENSITY, GENOTYPIC RESISTANCE, COMBINATION THERAPY, NUCLEOTIDE ANALOGS, ADEFOVIR DIPIVOXIL, TURNOVER MARKERS, NAIVE PATIENTS, ENTECAVIR, VIRUS, MANAGEMENT
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

BACKGROUND & AIMS: Tenofovir disoproxil fumarate (TDF) is active against lamivudine-resistant hepatitis B virus (HBV) infection, but data to support its clinical efficacy in this setting are limited.